Regulus Therapeutics Inc.

RGLSDelisted Jun 25, 2025

Industry: Pharmaceutical Preparations
SEC CIK: 0001505512

SEC filings (opens in a new tab)

Regulus Therapeutics Inc. was delisted on Jun 25, 2025; its insiders filed their last Form 4 on Jun 27, 2025; 75 institutions reported holding it in 13F filings for Q1 2025, worth $107.0M in total; no superinvestor held it.

Q4 2022 vs. Q3 2022

How the institutions holding Regulus Therapeutics Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022 All holders in Q3 2022

13F holders of RGLS: Q3 2022 compared with Q4 2022
Measure	Q3 2022	Q4 2022	Change
Holders	25	28	+3
Shares	8.12M	8.12M	+2.59K (0.0%)
Value	$13.8M	$11.1M	−$2.67M (−19.4%)

New holders (4)

Institutions that held Regulus Therapeutics Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to RGLS in Q4 2022
Institution	Shares	Value	% of portfolio
Citadel Advisors LLC	42,505	$58.2K	0.00%
Bank of America Corp	18	$24	0.00%
Morgan Stanley	15	$21	0.00%
Simplex Trading, LLC	301	$0	0.00%

Sold out (1)

Institutions that held Regulus Therapeutics Inc. at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of RGLS in Q4 2022
Institution	Shares, Q3 2022	Value, Q3 2022
HRT Financial LP	22,735	$38.0K